Clinical Trial Update: HORMA: Hormonal Regulators of Muscle and Metabolism in Aging [Phase 2]

View source ↗

Summary

Phase 2 trial HORMA studying hormonal regulators of muscle and metabolism in aging has completed, as reported by the National Institute on Aging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frailty
• Muscle Weakness
• Sarcopenia

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Sarcopenia, Muscle Weakness | Phase 2 | Status: COMPLETED